LobbyingHealthequity lobbying by quarter
Healthequity HQY's latest lobbying report covers Q2 2026, at $740K. The four quarters Q4 2025–Q3 2026 total $2.2M. Its first report covers Q4 2022; the issues it reports most are Taxation/Internal Revenue Code and Health Issues.
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $2.2M
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $300K | 2 |
| Q1 2023 | $530K | 2 |
| Q2 2023 | $350K | 2 |
| Q3 2023 | $360K | 2 |
| Q4 2023 | $550K | 3 |
| Q1 2024 | $740K | 3 |
| Q2 2024 | $730K | 3 |
| Q3 2024 | $1.1M | 3 |
| Q4 2024 | $600K | 3 |
| Q1 2025 | $790K | 3 |
| Q2 2025 | $1.4M | 3 |
| Q3 2025 | $640K | 3 |
| Q4 2025 | $605K | 2 |
| Q1 2026 | $820K | 2 |
| Q2 2026 | $740K | 2 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$5.2M · 32 reports
- Taxation$5.1M · 33 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES38 reports
- SENATE38 reports
- Executive Office of the President (EOP)3 reports
- White House Office3 reports
- Centers For Medicare and Medicaid Services (CMS)1 reports
- Health & Human Services, Dept of (HHS)1 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseHealthequity | $9.3M | 15 quarters |
| Bockorny Group | $345K | 5 quarters |
| Actum I | $330K | 12 quarters |
| Federal Policy Group | $300K | 6 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| JENNIFER KAUFMANN | Counsel/Rules Associate for Hon. Alcee Hastings (D-FL); Legal Intern, House Judiciary Committee; Deputy Scheduler, Sen. Ben Cardin (D-MD) | Q3 2025 |
| PETER LAWSON | Senior Counsel Rep. Jim Moran | Q2 2025 |
| AHARON FRIEDMAN | Tax Counsel, Committee on Ways and Means | Q1 2025 |
| KENNETH J KIES | Chief of Staff, Joint Committee on Taxation | Q1 2025 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | In-house | $660K |
| 07/20for Q2 | Bockorny Group | $80K |
| 04/20for Q1 | In-house | $740K |
| 04/20for Q1 | Bockorny Group | $80K |
| 01/20for Q4 2025 | In-house | $530K |
| 01/20for Q4 2025 | Bockorny Group | $75K |
| 25/10/20for Q3 2025 | In-house | $530K |
| 25/10/20for Q3 2025 | Bockorny Group | $110K |
| 25/10/19for Q3 2025 | Actum I | Under $5,000 |
| 25/07/21for Q2 2025 | In-house | $1.4M |
| 25/07/21for Q2 2025 | Bockorny Group | Under $5,000 |
| 25/07/20for Q2 2025 | Actum I | $30K |
| 25/06/26for Q2 2025 | Bockorny Group | Under $5,000 |
| 25/04/21for Q1 2025 | In-house | $700K |
| 25/04/16for Q1 2025 | Actum I | $30K |
| 25/03/28for Q1 2025 | Federal Policy Group | $60K |
| 25/01/21for Q4 2024 | Federal Policy Group | Under $5,000 |
| 25/01/20for Q4 2024 | Actum I | $30K |
| 25/01/19for Q4 2024 | In-house | $570K |
| 24/10/21for Q3 2024 | In-house | $930K |